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Background: A range of physical therapies (including airway clearance and physical
training) are used in cystic fibrosis (CF). The aim of this paper is to summarise the
main findings from Cochrane systematic reviews that have considered the evidence
for physical therapies in CF.
Methods: All outcomes reported in relevant Cochrane systematic reviews are
summarised.
Results: Review 1 provides some evidence from short-term trials of the benefit of
airway clearance over no airway clearance in improved mucus transport but no
definitive evidence from long-term trials to support the efficacy of airway clearance
over no airway clearance; review 2 provides some evidence that conventional chest
physiotherapy (CCPT) is at least as effective as other forms of airway clearance, but
that patients may have a preference for self-administered treatments over CCPT;
review 3 provides some evidence that positive expiratory pressure (PEP) is at least as
effective as other forms of airway clearance; review 4 provides some evidence to
support the use of non-invasive ventilation during airway clearance in patients with
moderate to severe disease who have difficulty clearing sputum; review 5 provides
some evidence of the benefits of different types of physical training.Published by Elsevier Ltd.
rane reviews sited in this evidence-based review.
ehabilitation Sciences Research Institute, University of Ulster, Northern Ireland, BT37 OQB, UK.
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some evidence to support the inclusion of physical therapies in the care-manage-
ment plan of CF. They also provide information to steer the direction and focus of
future research in this area.
& 2006 Published by Elsevier Ltd.Background
Cystic fibrosis (CF) is a multisystem disease;
however, the major clinical manifestations are
related to respiratory disease. Patients with CF
are infected early in life with Staphylococcus
aureus and Haemophilus influenzae, and later with
Pseudomonas aeruginosa. Numerous trials have
shown how the host inflammatory response to these
early infections contributes to the chronicity of
infection and the progression of respiratory dis-
ease. The major clinical manifestations of CF
respiratory disease are retention of sputum, re-
duced exercise capacity and breathlessness.1 Phy-
sical therapy involves a range of interventions
(including airway clearance and physical training),
which have an overall aim of reducing progression
of CF respiratory disease. Many different airway
clearance techniques are available, but, in general,
their goal is to reduce disease progression by
augmenting the normal mucociliary clearance
mechanism of the lungs and facilitating expectora-
tion (Table 1).2–4 Outcome measures currently used
to assess the efficacy of airway clearance fre-
quently include the following: auscultation; spiro-
metry; pulse oximetry and sputum weight or
volume. Less frequently used outcome measures
include radioaerosol clearance; arterial blood
gases; cough frequency; health-related quality of
life (QoL); breathlessness; sputum cultures; X-rays;
antibiotic use and frequency of exacerbations. The
primary aims of physical training are to improve
exercise capacity, improve muscle strength, and
reduce breathlessness, although it may also have an
airway clearance effect. Outcome measures cur-
rently used to assess the efficacy of physical
training include peak or endurance exercise tests;
weight and body-mass index and breathlessness
scales. Less frequently used outcome measures
include specific muscle strength, endurance or
flexibility tests; health-related QoL; activity diaries
or monitors; antibiotic use and frequency of
exacerbations.
It is essential that the benefit of these therapies
are established in order to justify their inclusion in
the demanding CF care package, and ensure that
any future research will add to and not replicate
existing evidence in this area.5The aim of this paper is to summarise the main
findings of Cochrane systematic reviews that have
considered the evidence for physical therapies
(airway clearance and physical training) in CF.Methods
Five Cochrane systematic reviews were identified
that assessed the efficacy of various physical
therapies (chest physiotherapy,6 conventional
physiotherapy,7 positive expiratory pressure
(PEP),8 non-invasive ventilation (NIV)9 and physical
training10) in CF. The trials in the Cochrane
systematic reviews were all randomised trials,
including patients with CF (diagnosed on the
basis of clinical criteria, sweat testing or genotype
analysis) of any age and any degree of disease
severity. The search strategies and methods
used for trial eligibility, trial quality and data
extraction, followed the guidelines of the Cochrane
Cystic Fibrosis and Genetic Disorders Group. Spe-
cific information on population, interventions,
types of outcome measures and quality can be
obtained from the ‘‘Table of Characteristics of
Included Trials’’ in the individual Cochrane sys-
tematic reviews. Original trial data are also
provided in the individual Cochrane systematic
reviews. Only one of the reviews conducted a
meta-analysis of results.7 For this paper, all out-
comes reported in the Cochrane systematic reviews
will be referred to.Systematic review 1
Airway clearance compared with no airway
clearance in CF
Six randomised, crossover trials were included in
this review: all were short-term trials (five
trials were single-treatment trials11–15 and
one trial lasted up to 7 days16), with a total
of 66 participants. These trials involved a mixed
population of adults and children.11–16 No data
on spirometry were available to facilitate
classification of disease severity. Any form of
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Table 1 Definition of techniques used in this review.
Airway clearance technique Description
Chest/conventional physiotherapy (CCPT) This technique has traditionally included postural drainage,
percussion and vibration. Postural drainage is a technique in
which the patient is positioned to facilitate gravity drainage of
secretions from the airways. Percussion is a technique of
clapping the chest wall. Vibration applies fine shaking of the
chest wall, usually during the expiratory phase. Percussion and
vibration can be applied using either manual or mechanical
techniques.
Postural drainage with percussion and vibration
(PDPV)
Active cycle of breathing techniques (ACBT) This technique includes breathing control, thoracic expansion
techniques, forced expiration technique (FET), and may include
CPT.
Forced expiration technique (FET) Sometimes called huff coughing, this technique consists of one
or two huffs from mid-to-low lung volumes with the glottis
open, followed by relaxed diaphragmatic breathing.
Positive expiratory pressure (PEP) This technique uses a device, through which the patient exhales
against a pressure of 10–20 cmH2O. During high PEP, the patient
exhales against a pressure ranging from 40 to 100 cmH2O.
Airway oscillating device (AOD): flutter This technique uses a device that produces PEP with oscillations
in the airway during the expiratory phase.
Autogenic drainage (AD) This is a three-level breathing sequence beginning at low lung
volumes, followed by breathing at mid-lung volumes, followed
by deep breathing, huff and coughing.
Airway oscillating device (AOD): intrapulmonary
percussive ventilation (IPV)
This technique uses a pneumatic, oscillating pressure device
that generates oscillations in the range of 100–300/min at
pressures of 535 cmH2O.
High-frequency chest compression (HFCC) This technique uses an inflatable vest that attaches by hoses to
an airpulse generator producing pressures to about 50 cmH2O at
frequencies of 5–25Hz.
Mechanical percussion Electrical hand-held device used to provide chest wall
percussion.
Pursed-lip breathing Involves inhaling through nose slowly and exhaling through
pursed lips.
Non-invasive ventilation (NIV) Device that consists of mouthpiece or facemask connected to
generator that provides a set positive pressure on inspiration
and expiration.
Evidence for physical therapies in CF 193airway clearance (conventional chest physiother-
apy (CCPT),11,12,15,16 PEP,12–16 active cycle of
breathing techniques (ACBT),16 autogenic drainage
(AD),14 mechanical percussion,11 high-frequency
chest compression (HFCC)16) was compared with
no airway clearance or spontaneous coughing
alone.Spirometry and plethysmography
Two trials found no significant difference between
airway clearance and no airway clearance in post-treatment total lung capacity (TLC) and functional
residual capacity.13,16Secretion expectoration and mucus
transport
Five trials found increased mucus transport11,12,15
or secretion expectoration11,14,17 during airway
clearance than during no airway clearance. In
the only trial that did not find a significant
difference in mucus transport between airway
clearance compared with no airway clearance,
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clearance regimen.13
Practice point
 The long-term effect of no airway clearance
is unknown, and short-term trials provide
some evidence of the benefit of airway
clearance over no airway clearance in
improved mucus transportSystematic review 2
Conventional chest physiotherapy compared
with other forms of airway clearance in CF
Fifteen trials of mixed designs were included in this
review (seven trials in this review overlapped with
those in systematic review 3,17–23 and one trial
overlapped with those in systematic review 524), with
a total of 475 participants. Four trials were under-
taken during an acute exacerbation and were of
10–16 days duration; six trials were undertaken
between 1 and 6 months and five trials were greater
than 1 year. In this review, trials that were less than 7
days duration were excluded (21 trials), and the
results for medium- and long-term trials were
grouped together to facilitate meta-analysis. The
trials involved adults only;17,26 children only18–21,23
and mixed populations of adults and chil-
dren.22,24,27–30 The age of the participants was not
recorded in two trials.23,31 Data on spirometry were
available in 10 trials and, in these trials, patients had
mild to moderate disease;20,22,30 two trials had
moderate to severe disease,24,26 and five had a broad
range of lung function.19,25,27–29 CCPT was compared
with any other individual form of airway clearance:
PEP;17–23 high-frequency chest compression, manual
or acoustic percussion (HFCC/MP);26,27,31 forced
expiration technique (FET);30 airway oscillating de-
vices (AOD);28,29 AD;23,25 or exercise.24
Spirometry and plethysmography
Meta-analysis showed no differences in forced
expiratory volume in 1 s (FEV1), forced vital
capacity (FVC) and forced expiratory flow25–75,
between CCPT and PEP,17,19–23 HFCC/MP,26,27,31
AOD,28,29 AD23,25 or exercise.24
Preference and adherence to therapy
The reporting of preference and adherence to
therapy outcomes were not always objective norin a format suitable for meta-analysis. In the trials
that reported on preference, patients tended to
prefer PEP,17–19,23 HFCC/MP,26,27 and AD23,25 to
CCPT. Only one trial reported on adherence, and
showed little difference between adherence to
CCPT and PEP.19 One other trial referred to an
adherence device but no data were available.22Quality of life
Insufficient data on QoL were available for meta-
analysis. One trial reported no difference in QoL
between PEP and CCPT.22Number of days in hospital per year
Data on number of days in hospital per year were
not in a format suitable for meta-analysis. Two
trials reported on this outcome and found no
difference in the number of hospital admissions in
CCPT compared with AOD28 or FET.30Number of admissions per year
Insufficient data on number of admissions per year
were available for meta-analysis. Two trials re-
ported on this outcome and found no difference in
the number of hospital admissions in CCPT com-
pared with PEP19 or FET.30Number of intravenous antibiotics per year
Insufficient data on the number of intravenous
antibiotics per year were available for meta-
analysis. Two trials reported on this outcome. One
trial reported that days on antibiotic therapy was
higher in the PEP group,18 and one trial showed no
difference in the number of oral and intravenous
antibiotics between the HFCC/MP and CCPT
groups.28Other
Other outcomes were inconsistently reported in the
trials, and, although few data were available on
these outcomes, no clear differences between
CCPT and other forms of airway clearance in
exercise capacity were observed,22,24,30 in TLC
and residual volume,17,24,26,29 mucus transport
rate,17 Schwachmann scores,19,30 sputum produc-
tion,20,21,26,31 bacteriology,19,30 cough,20,21
SpO2,
18,26 and nutritional status.26,28
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Adverse events were reported sporadically, and it
was stated that they may have been spontaneous or
unrelated to any of the interventions.
Practice points
 Medium- and long-term trials have shown
that CCPT is at least as effective as other
forms of airway clearance
 Patients tended to prefer techniques that
promoted independence to CCPTSystematic review 3
PEP compared with other forms of airway
clearance in CF
Twenty trials of mixed designs were included in this
review (seven trials in this review overlapped with
those in systematic review 2,17–23 and one trial
overlapped with systematic review 4.32 These trials
involved adults only;17 children only18–21,23,33–35
and mixed populations of adults and chil-
dren.12–16,22,32,36–39 Data on spirometry were avail-
able in 10 trials to facilitate classification of disease
severity. Spirometry ranged from normal to severe
in these 10 trials. Seven trials were single-treat-
ment trials,12–15,32,36,38 two trials were short-term
trials (treatment interventions up to 7 days)15,37
and 11 were longer term trials (2 weeks up to 2
years),17–23,33–35,39 with a total of 429 participants.
PEP was compared with several different air-
way clearance regimens, and a number of
trials had numerous comparison groups within each
trial: postural drainage with a combination of
breathing exercises, percussion, vibrations
(PDPV);12,16–23,34,36–39 high-frequency chest com-
pression;16 pursed-lipped breathing;36 NIV;32
AD;14,23 flutter;33–35 and control/spontaneous
coughing.12–16 PEP was also compared with exercise
prescribed for the purpose of airway clearance.38
Spirometry and plethysmography
Three single-treatment trials reported significant
differences in post-treatment spirometry/plethys-
mography: one trial found FVC was significantly
increased using PEP compared with conventional
physiotherapy;36 in one trial, functional residual
capacity and TLC was significantly increased usingPEP (15 cmH2O) compared with PEP (5 cmH2O);
13 in
one trial, FEV1 and FVC was significantly lower
using AD and PEP combined in one session com-
pared with AD alone.14 The other single and short-
term trials found no differences in spirometry using
PEP compared with any of the other airway
clearance regimens.12,15,16,32,37,38 One long-term
trial reported significant improvements in FEV1 or
FVC using PEP compared with PDPV.19 The other
long-term trials found no difference in spirome-
try17,20–23,33–35,39 or plethysmography17,35 using PEP
compared with other airway clearance regimens.Sputum expectoration or mucus clearance
Two single-treatment trials found significantly more
secretions were expectorated during PEP compared
with PDPV, pursed-lipped breathing36 or AD.14 In
one short-term trial, significantly more secretions
were expectorated during PDPV compared with
PEP.37 Other single-treatment and short-term trials
found no difference in sputum expectoration during
PEP compared with other airway clearance regi-
mens.12,16,20,21 Five single-treatment trials mea-
sured mucus clearance. One trial showed that
clearance was significantly greater with PEP than
FET alone.15 The other trials showed no difference
in mucus clearance with PEP and the other
techniques.12,13,17,38Preference and adherence to therapy
This outcome was measured in nine trials. In one
single-treatment trial, patients preferred PEP to
other techniques (PDPV or pursed-lip breathing)36
and, in another trial, patients preferred NIV to
PEP.32 One short-term trial showed no difference in
preferences between PEP and other techniques
(PDPV, HFCC or cough).16 In the six longer term
trials, PEP was preferred to the other treatment
techniques.17–19,23,33,39 Two long-term trials re-
ported on adherence, and found no clear differ-
ences between PEP and PDPV19 and flutter.33Blood oxygen levels
In one single-treatment trial, the improvement in
SpO2 was significantly lower with PEP compared
with NIV.32 In one short-term trial, no significant
differences were found in SpO2 in the middle or
after treatment when PEP was compared with
PDPV,37 and, in the other short-term trial, SpO2
was greater in PEP than in other techniques.36
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In a long-term trial, the PEP group had a signifi-
cantly reduced rate of hospital admissions com-
pared with the flutter group.33
Other
In two long-term trials, when PEP was compared
with PDPV, no difference in well-being was ob-
served.22 Increased bronchial markings were sig-
nificantly less common in the PEP group compared
with the PDPV group.18 In two other longer trials,
no difference was reported in radiographic scores
in PEP compared with PDPV19 and flutter.33
Adverse events
Two long-term trials found no clear differences in the
number of adverse events between PEP and PDPV.18,19Practice point
 Single, short and longer term trials show
that PEP is at least as effective as other
forms of airway clearanceSystematic review 4
Airway clearance with non-invasive
ventilation compared with airway clearance
with no non-invasive ventilation in CF
Three randomised, crossover trials, which compared
a single-treatment session of airway clearance with
NIV, with airway clearance without NIV were in-
cluded, with a total of 62 participants (one trial
overlapped with systematic review 3;32 one trial
involved adults only;40 one trial involved children
only;41 and one trial involved a mixed population of
adults and children.32 Data on spirometry indicated
that one trial included patients with mild disease;
one trial included patients in all disease categories
and one trial included patients with severe disease.
NIV for airway clearance was compared with PEP32 or
ACBT/FET.40,41
Spirometry and plethysmography
No difference was reported in post-treatment
spirometry (FEV1, FVC, FEF25–75) using NIV com-
pared with PEP or ACBT/FET.32,40,41Respiratory rate was significantly lower during
NIV than during ACBT/FET.41 Post-treatment PImax
and PEmax were significantly greater after NIV
compared with PEP or ACBT/FET.40,41
Sputum expectoration and mucus clearance
No significant difference was observed in the
amount of sputum expectorated during NIV com-
pared with ACBT/FET.40,41
Blood oxygen levels
SpO2 improved significantly when NIV was used for
airway clearance compared with PEP or ACBT/
FET.32,40,41
Respiratory symptom scores
In one trial, most participants considered expec-
toration to be easier and felt less tired with NIV
compared with FET.41 No difference was found in
the Borg breathlessness score after treatment with
NIV compared with ACBT.40
Adherence to treatment and preference
Most patients stated that they preferred NIV to PEP
or ACBT/FET.32,40,41 Most physiotherapists found it
easier to perform airway clearance using NIV.41
Practice points
 Short-term trials show that NIV is more
effective than other airway clearance regi-
mens in patients with more severe disease
who have difficulty clearing sputum
 The long-term effect of NIV used for airway
clearance is unknownSystematic review 5
Physical training compared with no physical
training in CF
Seven trials using randomised parallel-group design
were included (one trial in this review overlapped
with those in systematic review 224); four short-
term trials (inpatient up to 1 month) and three
long-term trials (outpatient based up to 3 years),
with a total of 231 participants. One trial
included adults only,42 three trials included chil-
dren only43–45 and three trials included a mixed
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Disease severity based on spirometry ranged from
mild to severe disease. Physical training was
compared with airway clearance,24 normal activity
or no specific training.42–47 The results were
reported under effects of aerobic training com-
pared with no training and anaerobic training
compared with no training.
Aerobic versus no physical training
Exercise capacity
One short-term trial showed a significant improve-
ment in exercise tolerance44 but a long-term trial
did not.47 Most short- and long-term trials reported
no significant difference in physiological responses
during exercise testing in physical training com-
pared with airway clearance;24 no training;44 or
normal activity.47 However, in a long-term trial,
training was significantly reduced compared with
normal activity in the ratio of peak-minute ventila-
tion/peak-load during arm ergometry; lactate was
also significantly reduced during bicycle ergometry
in training compared with normal activity.42
Specific indices of strength, mass effort and
general fatigue
In a short-term trial, aerobic training resulted in a
significantly greater increase in lower limb strength
than no specific physical training.44
Spirometry/plethysmography
In two short-term trials, no significant differences
were found in spirometry after aerobic training
compared with bronchial hygiene24 or no specific
physical training.44 Longer term trials showed that
aerobic physical training had no significant effect
on FEV1 but a significant and positive effect on FVC
compared with normal activity.42,47
Symptom scores
In a short-term trial, no significant differences
were found between physical training and bronchial
hygiene in the number of coughs or in dry sputum
weight or volume.24
Weight
One short-term trial found no significant difference
in weight change or fat-free mass when aerobic
training was compared with no specific training.44
The long-term trials also showed no significant
change in body-mass index or annual rate of decline
in per cent ideal weight for height in aerobic
training compared with normal activity.42,47Adherance with physical training
In one long-term trial, adherence was rated
between partial and full.47Other
Aerobic physical training did not significantly affect
the number of acute exacerbations requiring
hospitalisation or compliance with other treat-
ments compared with normal activity.47Anaerobic training compared with no
physical training
Exercise capacity
No improvement in exercise capacity was observed
in short-term anaerobic physical training compared
with no specific physical training;44 however, a
long-term trial showed a significantly greater
improvement in VO2 peak in anaerobic physical
training compared with normal activity.45 One long-
term trial reported significantly lower lactate
levels with anaerobic training compared with
normal activity.45Specific indices of strength, mass effort and
general fatigue
In both short- and long-term trials, parameters of
strength in the physical training group was sig-
nificantly increased compared with no specific
physical training44 or normal activity.44Spirometry/plethysmography
In a short-term trial, the anaerobic training group
showed a significantly greater mean percentage
increase in FEV1 compared with no specific physical
training.44 No significant differences were observed
in FVC in the anaerobic training group compared
with no specific physical training44 or normal
activity.45QoL
In one long-term trial, physical function was no
different between anaerobic training and normal
activity.45Weight
In one short-term trial, there was significantly
greater change in weight and change in fat-free
mass in the anaerobic group than no specific
training.44 In one long-term trial, no significant
difference was observed in change in body compo-
sition between anaerobic training and normal
activity.45
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In one long-term trial, adherence was reported to
be 98%. The reasons for absence were holidays or
sickness.45
Practice points
 Short- and longer term trials show some
benefit of physical training compared with
no physical training
 There is no evidence to support or refute
the substitution of airway clearance ses-
sions with physical trainingDiscussion and conclusions
This paper summarises the evidence from Cochrane
systematic reviews regarding the efficacy of physi-
cal therapies (airway clearance and physical train-
ing) currently included in the CF care-management
plan. No definitive evidence is available from the
Cochrane systematic reviews regarding the long-
term efficacy of airway clearance over no airway
clearance. There is widespread consensus among
patients and health professionals that airway
clearance is an essential component of CF care
and so, despite ‘‘lack of evidence’’, it is unlikely
that any future trials will be carried out to establish
the long-term efficacy of airway clearance com-
pared with no airway clearance in CF. One excep-
tion to this is the role of airway clearance in
asymptomatic patients with little consensus on
whether airway clearance is necessary or if the
proposed benefits are outweighed by proposed
deleterious effects. Whether a trial to address this
important question is ethical is currently a matter
of much debate.
Irrespective of the exact mechanisms, airway
clearance regimens promote mucociliary clearance
by altering airflow and mucous viscosity. Evidence
from the Cochrane systematic reviews support
current expert opinion that no one airway clear-
ance regimen is better than another. It is likely that
specific airway clearance regimens may be more
effective in some circumstances (e.g. one of the
Cochrane systematic reviews supports the use of
NIV compared with other airway clearance regi-
mens in patients with more severe disease who
have difficulty clearing sputum). Unfortunately, the
reviews could not provide evidence-based guidance
on what therapies are most effective in which
circumstances, and this should be the focus of
future research in this area (e.g. establishingefficacy of treatments in specific subgroups of
patients5).
Few of the trials in this review report on
adherence; however, other trials have shown that
adherence to airway clearance and exercise in CF is
generally reported to be poor (40–55%).48 Data
are consistent that treatment factors (the duration
and the complexity of the treatment) or trait
factors (worry and confidence in medical practi-
tioners) are important determinants of adherence;
however, although they have some explanatory
value, significant amounts of the variance in
adherence behaviours is unaccounted for and
warrants further trial. Research needs to focus on
what the minimum criteria for adherence in
relation to airway clearance and exercise is
(i.e. how much is enough), and strategies to
maximise adherence in different sub-groups of
patients need to be developed and incorporated
into care packages.
One of the reviews provided evidence that
individuals may prefer airway clearance regimens
that are self-administered and facilitate indepen-
dence. The specific regimen chosen can be alter-
nated within an airway clearance session and
during different stages of disease (e.g. patients
may prefer an independent airway regimen during a
stable phase of disease and a more passive regimen
during an acute exacerbation). Physical therapists
involved in the care of patients with CF should
ensure that they are competent in the use of
currently available and any new physical therapy
interventions, so that both the patients and
physical therapist has maximum choice of treat-
ment options.
Some patients (either on the advice of the cystic-
fibrosis team or independently) substitute airway
clearance sessions with physical exercise. The
reviews in this paper do not provide enough
evidence to support or refute this practice. There
is some evidence to support the inclusion of
physical training in the care-management plan of
CF. The benefits obtained from including physical
training in a package of care may be influenced by
the type of training programme, and the inclusion
of both aerobic and anaerobic training are probably
important. Physical training is already part of the
care package offered to most patients with CF, and
there is an absence of evidence to actively
discourage this.
Potential adverse events from physical therapies
include dyspnoea, gastro-oesophageal reflux,
bronchospasm, hypoxaemia, pain, fatigue, dehy-
dration and haemoptysis, and, to a lesser extent,
rib fractures and pneumothorax. The incidence of
adverse events reported in these reviews was low.
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relative contra-indications to treatments. Where
adverse events occur, most are reversible with
termination or modification of the physical therapy.
Therefore, the occurrence or potential for adverse
events should be reported using a standard format
in future trials so that they can be used to guide
treatment choice.
A number of limitations apply to all the Cochrane
systematic reviews included in this overview.
Most of the trials in the individual reviews included
relatively small numbers of patients. Not all
trials reported on each key outcome, and outcomes
are not reported in a consistent format. This
resulted in only one review conducting a meta-
analysis and, as such, summary estimates are not
available on the overall effect of many of the
interventions. Many of the trials in the systematic
reviews were crossover trials, which compared
the efficacy of one intervention with another
intervention with no control, placebo group, or
both. These Cochrane systematic reviews have only
summarised the results of randomised trials and, in
effect, ignored the huge amount of lower quality
evidence (non-randomised trials) investigating effi-
cacy of physical therapies in CF. It is important to
highlight, however, that most lower-quality trials
support the findings of these Cochrane systematic
reviews.
The trials in these Cochrane systematic reviews
are primarily short- to medium-term trials, and
only limited evidence is available from long-term
trials to support the inclusion of physical therapies
in the care-management plan for CF. Short-term
efficacy may not reflect long-term efficacy of an
intervention, and is therefore of limited relevance
in a chronic life-long condition such as CF. Short-
term trials should only be carried out to obtain
preliminary data on new techniques in order to
rationalise the need for a longer term trial.
A consensus urgently needs to be reached on
which outcome measures are appropriate for
physical therapy trials. Improved therapies have
progressively slowed the decline in spirometry over
the past few decades, and, consequently, the
sensitivity of spirometry as a measure of short- to
medium-term efficacy in physical therapy trials is
probably questionable. Nevertheless, spirometry
remains a strong predictor of mortality, and there-
fore should remain a primary outcome measure in
longer term trials. As current evidence suggests
that physical therapy interventions are equally
beneficial, treatment duration, patient preference
and patient adherence may be important primary
outcomes. Other outcomes, such as frequency of
exacerbations, quality of life or antibiotics mayalso be important. The association between
sputum output and spirometry or disease pro-
gression is unclear, and consequently the relevance
or validity of sputum output in physical therapies
trials is often debated. Despite this, patients
use sputum output to measure the relative ef-
fectiveness of different airway clearance
regimens and, therefore, in our opinion, this is an
important outcome measure in airway clearance
trials. To facilitate inclusion of future trials in
systematic reviews, it is essential that consensus is
reached on both the specific outcome measure-
ment tools used and on the method of reporting
outcomes.
Physical therapies are part of the care-manage-
ment plan in CF. The Cochrane systematic reviews
summarised in this review provide some evidence
to support this practice and no evidence to
discourage their inclusion. These Cochrane sys-
tematic reviews provide a clear summary of
previous research findings as well as rationale for
further research to expand the evidence base for
physical therapies in CF.References
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